Article

Solution Structure of the Methyl-CpG Binding Domain of Human MBD1 in Complex with Methylated DNA

Graduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, 630-0101, Nara, Japan.
Cell (Impact Factor: 33.12). 06/2001; 105(4):487-97. DOI: 10.1016/S0092-8674(01)00324-5
Source: PubMed

ABSTRACT In vertebrates, the biological consequences of DNA methylation are often mediated by protein factors containing conserved methyl-CpG binding domains (MBDs). Mutations in the MBD protein MeCP2 cause the neurodevelopmental disease Rett syndrome. We report here the solution structure of the MBD of the human methylation-dependent transcriptional regulator MBD1 bound to methylated DNA. DNA binding causes a loop in MBD1 to fold into a major and novel DNA binding interface. Recognition of the methyl groups and CG sequence at the methylation site is due to five highly conserved residues that form a hydrophobic patch. The structure indicates how MBD may access nucleosomal DNA without encountering steric interference from core histones, and provides a basis to interpret mutations linked to Rett syndrome in MeCP2.

Download full-text

Full-text

Available from: Izuru Ohki, Feb 10, 2015
0 Followers
 · 
86 Views
  • Source
    • "In addition, we introduced amino acid substitutions at conserved residues of the MBD domains from MBD1 (R22C), MBD2 (R181C), and MBD4 (R106C). These mutations have previously been shown to disrupt specificity toward methylated DNA (Free et al., 2001; Ohki et al., 2001; Scarsdale et al., 2011) (Figure S4A). Similar to their wild-type counterparts, we inserted the tagged variants into the same genomic site and under the control of the same promoter. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To gain insight into the cellular readout of DNA methylation, we established a strategy for systematically profiling the genome-wide distribution of chromatin-interacting factors. This enabled us to create genomic maps for the methyl-CpG-binding domain (MBD) family of proteins, including disease-relevant mutants, deletions, and isoforms. In vivo binding of MBD proteins occurs predominantly as a linear function of local methylation density, requiring functional MBD domains and methyl-CPGs. This interaction directs specificity of MBD proteins to methylated, CpG-dense, and inactive regulatory regions. In contrast, binding to unmethylated sites varies between MBD proteins and is mediated via alternative domains or protein-protein interactions. Such targeting is exemplified by NuRD-complex-mediated tethering of MBD2 to a subset of unmethylated, active regulatory regions. Interestingly, MBD3 also occupies these sites, but like MBD2, binding is independent of the presence of hydroxymethylation. These functional binding maps reveal methylation-dependent and -independent binding modes and revise current models of DNA methylation readout through MBD proteins.
    Cell 04/2013; 153(2):480-92. DOI:10.1016/j.cell.2013.03.011 · 33.12 Impact Factor
  • Source
    • "Zfp57 and MBD proteins share a common mode of 5mC recognition Two other protein domains—namely, SET and RINGassociated (SRA) domain (Arita et al. 2008; Avvakumov et al. 2008; Hashimoto et al. 2008; Rajakumara et al. 2011) and MBD (Ohki et al. 2001; Ho et al. 2008; Scarsdale et al. 2011)—have been structurally characterized in their recognition of 5mC. The mammalian SRA domain flips the 5mC of a hemimethylated CpG into a binding cage with the methyl group in hydrophobic interactions with the side chains of two tyrosines and one serine (Supplemental Fig. S3A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Zinc finger transcription factor Zfp57 recognizes the methylated CpG within the TGCCGC element. We determined the structure of the DNA-binding domain of Zfp57, consisting of two adjacent zinc fingers, in complex with fully methylated DNA at 1.0 Å resolution. The first zinc finger contacts the 5' half (TGC), and the second recognizes the 3' half (CGC) of the recognition sequence. Zfp57 recognizes the two 5-methylcytosines (5mCs) asymmetrically: One involves hydrophobic interactions with Arg178, which also interacts with the neighboring 3' guanine and forms a 5mC-Arg-G interaction, while the other involves a layer of ordered water molecules. Two point mutations in patients with transient neonatal diabetes abolish DNA-binding activity. Zfp57 has reduced binding affinity for unmodified DNA and the oxidative products of 5mC.
    Genes & development 10/2012; 26(21). DOI:10.1101/gad.202200.112 · 12.64 Impact Factor
  • Source
    • "In the structure of Mbd1 bound to methylated DNA, Y34 is located immediately adjacent to the 5-methyl group of 5mC (Ohki et al., 2001; Figure S6E). Thus, loss of the hydroxyl group (Y34F) at this position in Mbd3 could almost perfectly compensate for the additional hydroxyl group in 5hmC relative to 5mC, thus allowing direct binding of Mbd3 to this modification in a manner structurally analogous to the binding of remaining Mbd members to 5mC. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Numerous chromatin regulators are required for embryonic stem (ES) cell self-renewal and pluripotency, but few have been studied in detail. Here, we examine the roles of several chromatin regulators whose loss affects the pluripotent state of ES cells. We find that Mbd3 and Brg1 antagonistically regulate a common set of genes by regulating promoter nucleosome occupancy. Furthermore, both Mbd3 and Brg1 play key roles in the biology of 5-hydroxymethylcytosine (5hmC): Mbd3 colocalizes with Tet1 and 5hmC in vivo, Mbd3 knockdown preferentially affects expression of 5hmC-marked genes, Mbd3 localization is Tet1-dependent, and Mbd3 preferentially binds to 5hmC relative to 5-methylcytosine in vitro. Finally, both Mbd3 and Brg1 are themselves required for normal levels of 5hmC in vivo. Together, our results identify an effector for 5hmC, and reveal that control of gene expression by antagonistic chromatin regulators is a surprisingly common regulatory strategy in ES cells.
    Cell 12/2011; 147(7):1498-510. DOI:10.1016/j.cell.2011.11.054 · 33.12 Impact Factor
Show more